APA (7th ed.) Citation

Hu, W., Cui, X., Liu, H., Li, Z., Chen, X., Wang, Q., . . . Chen, L. (2025). CYP3A5 promotes glioblastoma stemness and chemoresistance through fine-tuning NAD+/NADH ratio. Journal of Experimental & Clinical Cancer Research (17569966), 1, 1. https://doi.org/10.1186/s13046-024-03254-x

Chicago Style (17th ed.) Citation

Hu, Wentao, et al. "CYP3A5 Promotes Glioblastoma Stemness and Chemoresistance Through Fine-tuning NAD+/NADH Ratio." Journal of Experimental & Clinical Cancer Research (17569966) 1 (2025): 1. https://doi.org/10.1186/s13046-024-03254-x.

MLA (9th ed.) Citation

Hu, Wentao, et al. "CYP3A5 Promotes Glioblastoma Stemness and Chemoresistance Through Fine-tuning NAD+/NADH Ratio." Journal of Experimental & Clinical Cancer Research (17569966), vol. 1, 2025, p. 1, https://doi.org/10.1186/s13046-024-03254-x.